A Knowledge Hub
Concord Biotech in the News
Concord Biotech Receives USFDA ANDA Approval for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL
fermentation-based Active Pharmaceutical Ingredients (APIs) and formulations, today
announced that it has received approval from the U.S. Food and Drug Administration (USFDA)
for its Abbreviated New Drug Application (ANDA) for Mycophenolate Mofetil for Oral Suspension
USP, 200 mg/mL
Read More...
Concord Biotech Limited received the 2024 DET Hurun Award
Concord Biotech Limited received the 2024 DET Hurun Award for Outstanding Contribution to India’s Manufacturing Economy at the India Manufacturing Excellence Awards 2025, organized by Hurun India in collaboration with the Dubai Department of Economy and Tourism, on February 25th, 2025, in Mumbai.
Korea MFDS successfully inspects our API Unit (Dholka)
Concord Biotech’s API Unit 1 (Dholka) has been successfully inspected by Korea MFDS from 18th to 20th February, reinforcing our commitment to global quality and compliance. This achievement highlights our dedication to maintaining the highest international pharmaceutical standards, ensuring that our products continue to meet the stringent regulatory requirements of global markets. As we expand our footprint worldwide, we continue to deliver excellence, innovation, and trust.
Best of Brussels Conference 2022 participation
Concord Biotech actively participated in the 10th International Best of Brussels (BOB) Conference 2022, held in Pune from 15th to 17th July 2022. The conference was organised by ISCCM, Pune. Workshops & Scientific sessions were conducted by engaging National & International speakers. More than 800 doctors across India participated in this conference.
Euro Asia 2022 participation
Concord Biotech participated in Euro Asia 2022, held in New Delhi from 30th June to 3rd July 2022. This was a joint conference of ESICM, Europe and ISCCM, India. More than 1200 delegates and speakers from India and Europe participated in the conference. The theme of the conference was “Connect-Learn-Save Lives”.
Concord Biotech amongst top 10 Indian BioPharma Companies in 2021
Concord Biotech, a leading fermentation based biotechnology expert is amongst the top 10 Indian BioPharma Companies in 2021. Concord Biotech is known for its core strength of manufacturing fermentation based biotechnology products catering to therapeutic segments like Oncology, Immunology, Anti-Infective etc.
Concord Biotech join hands with AlIMS for green energy initiative
Concord Biotech donated 2 electric SUVs to AIIMS, New Delhi as a part of its CSR initiative. This has supported AlIMS in its mission to provide patient care and a pollution free environment. The vehicles would be used to transport patients from one campus to another.
Criticare Conference participation
Concord Biotech attended the 28th Criticare conference, which Concord Biotech if took place from April 8″ to 10” at the Mahatma Mandir Convention Centre in Gandhinagar, Gujarat.
Researchers, professors, and young doctors in Intensive Care attended the conference to exchange knowledge and share their innovations with the rest of the world. Several topics were discussed, including revisiting clinical practices, new technologies and drugs, and current initiatives to deal with the new normal- the pandemic and post-pandemic scenario of critical care.
This conference was organized by the ISCCM (Indian Society of Critical Care Medicine), and we were recognized for our outstanding participation through the Stall and Faculty Lounge.
#ISCCM #criticare2022 #conference #IndianSocietyofCriticalCareMedicine #intensivecare #criticalcare #concordbictech
27" Annual Conference of Indian Society of Critical Care Medicine, CRITICARE 2021
Concord Biotech CRITICARE Concord Biotech participated in the 27″ Criticare Conference during 26th to 28th Feb 2021. The conference was held virtually due to COVID-19 pandemic. The theme of the conference was Safety & Efficiency amidst resource limitation. Doctors from various parts of India participated in this conference. The conference was organized by ISCCM (Indian Society of Critical Care Medicine) and Concord Biotech was recognized for its participation through digital stall for sharing knowledge.
Concord Biotech contributes to support R&D facility at GSFC university
As a part of its CSR initiative, Concord Biotech donated ₹1 Crore to GSFC University for setting up Biotechnology laboratories. This contribution will help develop the talent by nurturing the skills of students at the university which in turn | will help in shaping the career of students in Life sciences.
Concord Biotech selected for PLI scheme of Government
The PLI scheme for pharmaceuticals is a part of the Government’s flagship Atma Nirbhar Bharat plan which is aimed at enhancing India’s manufacturing capabilities and exports.
Concord Biotech being a leader in fermentation based API’s has commissioned a state of the art new API facility to manufacture niche fermentation based API’s in order to make India Atma Nirbhar in those products.
Green Initiative of Concord Biotech & IKDRC-ITS, Ahmedabad, Gujarat , India for Environmental Sustainability
Asapartofits CSR initiative, Concord Biotech contributed towards Green Initiative of IKDRC-ITS, Ahmedabad , Gujarat, India (Institute of Kidney Disease & Research Centre — Institute of transplant Sciences) by developing and maintaining of Public Park in the premises of Institute spreads over approximately 75000 sq.ft. The concept of Oxygen garden is created by planting more than one thousand plants and shrubs to ensure environmental sustainability and for the betterment of our society.
Concord Biotech & Himachal Pradesh State Government Signed a MoU
In the presence of honourable Chief Minister Shri. Jai Ram Thakur, MoU (Memorandum of Understanding) was signed between Concord Biotech & State Government of Himachal Pradesh on August 13”, 2021 for setting up of Rs. 500 crore fermentation based API manufacturing plant in Una District.
Concord Biotech commercialises Amphotericin B (API)
Concord Biotech commercialises Amphotericin B (API).
Concord Biotech manufactures niche fermentation based Biotechnology company, manufacturing. API’s across various therapeutics segment like Immunosuppressants, Oncology, Anti-infective & antifungals and supplies to global pharmaceutical companies.
Concord Biotech announces commissioning of one of the largest fermentation based manufacturing plant in Asia at Limbasi, Ahmedabad
Concord Biotech’s 3rd manufacturing plant is commissioned at Limbasi, Ahmedabad — Gujarat. This plant is one of the largest fermentation based manufacturing plant in Asia and will cater the demand of world class quality pharmaceutical products across the globe.
Concord Biotech announces submissions/registrations of fermentation products with different regulatory authorities in 2020-21
Concord Biotech announces submission/registration of Midostaurin API and Staurosporine technical with USFDA and other regulatory agencies to cater to global markets.
